Weaver Consulting Group’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-36
Closed -$1K 735
2020
Q3
$1K Hold
36
﹤0.01% 920
2020
Q2
$1K Hold
36
﹤0.01% 897
2020
Q1
$1K Buy
+36
New +$1.04K ﹤0.01% 805

Other funds holding RXL

Weaver Consulting Group's RXL Position: Q4 2020 in Review

Weaver Consulting Group sold out of ProShares Ultra Health Care (RXL) in Q4 2020, closing a stake of 36 shares — an estimated $1K sold.

Weaver Consulting Group first reported a position in RXL in Q1 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2020. 17 funds tracked by Wall St. Rank hold RXL as of Q4 2020.

  • Weaver Consulting Group reported no remaining ProShares Ultra Health Care position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 36 ProShares Ultra Health Care shares in Q4 2020, an estimated $1K.
  • Weaver Consulting Group first reported a position in ProShares Ultra Health Care in Q1 2020 and held it in 3 quarters.
  • Weaver Consulting Group's ProShares Ultra Health Care position peaked at $1K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.